株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

分子量マーカーの世界市場:2020年~2024年

Global Molecular Weight Marker Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 924249
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.31円で換算しております。
Back to Top
分子量マーカーの世界市場:2020年~2024年 Global Molecular Weight Marker Market 2020-2024
出版日: 2020年02月04日 ページ情報: 英文 120 Pages
概要

世界の分子量マーカー市場は、2020年から2024年の予測期間中に12%のCAGRで成長し、3億759万米ドルの規模に達する見込みです。同市場は、治療の発見と開発におけるポリアクリルアミドゲル電気泳動(SDS-PAGE)の大幅な使用が成長要因となっています。さらに、マイクロ流体チップ電気泳動の出現が、市場成長を後押しすると予想されています。

当レポートでは、世界の分子量マーカー市場について調査分析し、市場規模および成長率、市場動向、市場促進要因、課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • 序文
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 2019年の市場規模
  • 市場規模と予測(2019年~2024年)
  • 市場の見通し

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

第6章 市場セグメンテーション:製品別

  • 市場セグメンテーション:製品別
  • 比較:製品別市場規模と予測2019-2024
  • DNAマーカー
  • タンパク質マーカー
  • RNAマーカー
  • 市場機会:製品別

第7章 顧客情勢

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較-市場規模と予測2019-2024
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • 改良された分子量マーカーの入手可能性
  • マイクロ流体チップ電気泳動の出現
  • 費用対効果の高いゲル電気泳動の分子量マーカーの再利用に注目

第12章 ベンダー情勢

  • 概要
  • 情勢の革新
  • 競争シナリオ

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abcam Plc
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • New England Biolabs Inc.
  • Promega Corp.
  • QIAGEN NV
  • タカラバイオ
  • Thermo Fisher Scientific Inc.

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

目次
Product Code: IRTNTR40304

Technavio has been monitoring the global molecular weight marker market and it is poised to grow by USD 307.59 mn during 2020-2024, progressing at a CAGR of 12% during the forecast period. Our reports on global molecular weight marker market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by significant use of sds-page in therapeutic discoveries and developments. In addition, emergence of microfluidic chip electrophoresis is anticipated to boost the growth of the global molecular weight marker market as well.

Market Segmentation

Technavio's global molecular weight marker market is segmented as below:

Product

  • DNA Marker
  • Protein Marker
  • RNA Marker

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global molecular weight marker market growth

This study identifies emergence of microfluidic chip electrophoresis as the prime reasons driving the global molecular weight marker market growth during the next few years.

Prominent vendors in global molecular weight marker market

We provide a detailed analysis of around 25 vendors operating in the global molecular weight marker market, including some of the vendors such as Abcam Plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Takara Bio Inc. and Thermo Fisher Scientific Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

TABLE OF CONTENTS

01: EXECUTIVE SUMMARY

02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Currency conversion rates for US$

03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • DNA marker - Market size and forecast 2019-2024
  • Protein marker - Market size and forecast 2019-2024
  • RNA marker - Market size and forecast 2019-2024
  • Market opportunity by product

07: CUSTOMER LANDSCAPE

08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

09: DECISION FRAMEWORK

10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

11: MARKET TRENDS

  • Availability of improved molecular weight markers
  • Emergence of microfluidic chip electrophoresis
  • Focus on reuse of molecular weight markers for cost-effective gel
  • electrophoresis

12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abcam Plc
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • New England Biolabs Inc.
  • Promega Corp.
  • QIAGEN NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

15: EXPLORE TECHNAVIO

  • Exhibit 01: Global life sciences tools and services market
  • Exhibit 02: Segments of global life sciences tools and services market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendors key offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: DNA marker - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: DNA marker - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Protein marker - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Protein marker - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: RNA marker - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 25: RNA marker - Year-over-year growth 2020-2024 (%)
  • Exhibit 26: Market opportunity by product
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2019-2024 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Abcam Plc - Vendor overview
  • Exhibit 47: Abcam Plc - Business segments
  • Exhibit 48: Abcam Plc - Organizational developments
  • Exhibit 49: Abcam Plc - Geographic focus
  • Exhibit 50: Abcam Plc - Key offerings
  • Exhibit 51: Agilent Technologies Inc. - Vendor overview
  • Exhibit 52: Agilent Technologies Inc. - Business segments
  • Exhibit 53: Agilent Technologies Inc. - Organizational developments
  • Exhibit 54: Agilent Technologies Inc. - Geographic focus
  • Exhibit 55: Agilent Technologies Inc. - Segment focus
  • Exhibit 56: Agilent Technologies Inc. - Key offerings
  • Exhibit 57: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 58: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 59: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 60: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 61: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 62: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 63: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 64: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 65: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 66: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 67: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 68: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 69: Merck KGaA - Vendor overview
  • Exhibit 70: Merck KGaA - Business segments
  • Exhibit 71: Merck KGaA - Organizational developments
  • Exhibit 72: Merck KGaA - Geographic focus
  • Exhibit 73: Merck KGaA - Segment focus
  • Exhibit 74: Merck KGaA - Key offerings
  • Exhibit 75: New England Biolabs Inc. - Vendor overview
  • Exhibit 76: New England Biolabs Inc. - Product segments
  • Exhibit 77: New England Biolabs Inc. - Organizational developments
  • Exhibit 78: New England Biolabs Inc. - Key offerings
  • Exhibit 79: Promega Corp. - Vendor overview
  • Exhibit 80: Promega Corp. - Business segments
  • Exhibit 81: Promega Corp. - Key offerings
  • Exhibit 82: QIAGEN NV - Vendor overview
  • Exhibit 83: QIAGEN NV - Product segments
  • Exhibit 84: QIAGEN NV - Organizational developments
  • Exhibit 85: QIAGEN NV - Geographic focus
  • Exhibit 86: QIAGEN NV - Segment focus
  • Exhibit 87: QIAGEN NV - Key offerings
  • Exhibit 88: Takara Bio Inc. - Vendor overview
  • Exhibit 89: Takara Bio Inc. - Business segments
  • Exhibit 90: Takara Bio Inc. - Geographic focus
  • Exhibit 91: Takara Bio Inc. - Segment focus
  • Exhibit 92: Takara Bio Inc. - Key offerings
  • Exhibit 93: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 94: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 95: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 96: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 97: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 98: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 99: Validation techniques employed for market sizing
  • Exhibit 100: Definition of market positioning of vendors
Back to Top